[1]
C.-M. Oblitas, F. Galeano-Valle, L. V.-D. La Cruz, J. D. Toro-Cervera, and P. Demelo-Rodríguez, “Omalizumab as a Provoking Factor for Venous Thromboembolism”, dti, vol. 13, no. 1, Jul. 2019.